KLONOPIN Drug Patent Profile
✉ Email this page to a colleague
When do Klonopin patents expire, and when can generic versions of Klonopin launch?
Klonopin is a drug marketed by Cheplapharm and Roche and is included in two NDAs.
The generic ingredient in KLONOPIN is clonazepam. There are ten drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the clonazepam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Klonopin
A generic version of KLONOPIN was approved as clonazepam by TEVA on September 10th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for KLONOPIN?
- What are the global sales for KLONOPIN?
- What is Average Wholesale Price for KLONOPIN?
Summary for KLONOPIN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 47 |
| Clinical Trials: | 8 |
| Patent Applications: | 4,328 |
| Drug Prices: | Drug price information for KLONOPIN |
| What excipients (inactive ingredients) are in KLONOPIN? | KLONOPIN excipients list |
| DailyMed Link: | KLONOPIN at DailyMed |
Recent Clinical Trials for KLONOPIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| New York State Psychiatric Institute | Phase 2 |
| National Institute on Drug Abuse (NIDA) | Phase 2 |
| Palo Alto Veterans Institute for Research | Phase 4 |
Pharmacology for KLONOPIN
| Drug Class | Benzodiazepine |
US Patents and Regulatory Information for KLONOPIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cheplapharm | KLONOPIN | clonazepam | TABLET;ORAL | 017533-005 | Apr 9, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Roche | KLONOPIN RAPIDLY DISINTEGRATING | clonazepam | TABLET, ORALLY DISINTEGRATING;ORAL | 020813-002 | Dec 23, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cheplapharm | KLONOPIN | clonazepam | TABLET;ORAL | 017533-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Roche | KLONOPIN RAPIDLY DISINTEGRATING | clonazepam | TABLET, ORALLY DISINTEGRATING;ORAL | 020813-003 | Dec 23, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for KLONOPIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Cheplapharm | KLONOPIN | clonazepam | TABLET;ORAL | 017533-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Cheplapharm | KLONOPIN | clonazepam | TABLET;ORAL | 017533-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Cheplapharm | KLONOPIN | clonazepam | TABLET;ORAL | 017533-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
